5-Fluorouracil-induced RNA stress engages a TRAIL-DISC-dependent apoptosis axis facilitated by p53

被引:22
作者
Akpinar, Birce [1 ]
Bracht, Ethiene V. [1 ]
Reijnders, Dorin [1 ]
Safarikova, Barbora [2 ]
Jelinkova, Iva [2 ]
Grandien, Alf [3 ]
Vaculova, Alena Hyrslova [1 ,2 ]
Zhivotovsky, Boris [1 ]
Olsson, Magnus [1 ]
机构
[1] Karolinska Inst, Inst Environm Med, Div Toxicol, S-10401 Stockholm, Sweden
[2] Acad Sci Czech Republic, Inst Biophys, Dept Cytokinet, Vvi, CS-61265 Brno, Czech Republic
[3] Karolinska Inst, Karolinska Univ Hosp Huddinge, Ctr Infect Med, Dept Med, Stockholm, Sweden
关键词
colon cancer; apoptosis; 5-fluorouracil; p53; necrosis; COLON-CANCER CELLS; CARCINOMA-CELLS; DNA-DAMAGE; IN-VIVO; THERAPEUTIC AGENTS; DEATH; GENE; ACTIVATION; INHIBITORS; EXPRESSION;
D O I
10.18632/oncotarget.6030
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Despite recent advances in targeted therapeutics, administration of 5-fluorouracil (5-FU) remains a common clinical strategy for post-surgical treatment of solid tumors. Although it has been proposed that RNA metabolism is disturbed by 5-FU treatment, the key cytotoxic response is believed to be enzymatic inhibition of thymidylate synthase resulting in nucleotide pool disproportions. An operating p53 tumor suppressor signaling network is in many cases essential for the efficiency of chemotherapy, and malfunctions within this system remain a clinical obstacle. Since the fate of chemotherapy-insensitive tumor cells is rarely described, we performed a comparative analysis of 5-FU toxicity in p53-deficient cells and conclude that p53 acts as a facilitator rather than a gatekeeper of cell death. Although p53 can act as a regulator of several cellular stress responses, no rerouting of cell death mode was observed in absence of the tumor suppressor. Thus, the final death outcome of 5-FU-treated p53-/-cells is demonstrated to be caspase-dependent, but due to a slow pace, accumulation of mitochondrial reactive oxygen species contributes to necrotic characteristics. The oligomerization status of the p53 target gene DR5 is determined as a significant limiting factor for the initiation of caspase activity in an intracellular TRAIL-dependent manner. Using several experimental approaches, we further conclude that RNA-rather than DNA-related stress follows by caspase activation irrespectively of p53 status. A distinct 5-FU-induced stress mechanism is thereby functionally connected to a successive and discrete cell death signaling pathway. Finally, we provide evidence that silencing of PARP-1 function may be an approach to specifically target p53-deficient cells in 5-FU combinatorial treatment strategies. Together, our results disclose details of impaired cell death signaling engaged as a consequence of 5-FU chemotherapy. Obtained data will contribute to the comprehension of factors restraining 5-FU efficiency, and by excluding DNA as the main stress target in some cell types they propose alternatives to currently used and suggested synergistic treatment regimens.
引用
收藏
页码:43679 / 43697
页数:19
相关论文
共 46 条
[1]
AIF promotes chromatinolysis and caspase-independent programmed necrosis by interacting with histone H2AX [J].
Artus, Cedric ;
Boujrad, Hanan ;
Bouharrour, Aida ;
Brunelle, Marie-Noelle ;
Hoos, Sylviane ;
Yuste, Victor J. ;
Lenormand, Pascal ;
Rousselle, Jean-Claude ;
Namane, Abdelkader ;
England, Patrick ;
Lorenzo, Hans K. ;
Susin, Santos A. .
EMBO JOURNAL, 2010, 29 (09) :1585-1599
[2]
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase [J].
Bryant, HE ;
Schultz, N ;
Thomas, HD ;
Parker, KM ;
Flower, D ;
Lopez, E ;
Kyle, S ;
Meuth, M ;
Curtin, NJ ;
Helleday, T .
NATURE, 2005, 434 (7035) :913-917
[3]
Disruption of p53 in human cancer cells alters the responses to therapeutic agents [J].
Bunz, F ;
Hwang, PM ;
Torrance, C ;
Waldman, T ;
Zhang, YG ;
Dillehay, L ;
Williams, J ;
Lengauer, C ;
Kinzler, KW ;
Vogelstein, B .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (03) :263-269
[4]
5-Fluorouracil signaling through a calcium-calmodulin-dependent pathway is required for p53 activation and apoptosis in colon carcinoma cells [J].
Can, G. ;
Akpinar, B. ;
Baran, Y. ;
Zhivotovsky, B. ;
Olsson, M. .
ONCOGENE, 2013, 32 (38) :4529-4538
[5]
Characterization of the human FLICE-inhibitory protein locus and comparison of the anti-apoptotic activity of four different FLIP isoforms [J].
Djerbi, M ;
Darreh-Shori, T ;
Zhivotovsky, B ;
Grandien, A .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2001, 54 (1-2) :180-189
[6]
Enhanced Antitumor Efficacy of a DR5-Specific TRAIL Variant over Recombinant Human TRAIL in a Bioluminescent Ovarian Cancer Xenograft Model [J].
Duiker, Evelien W. ;
de Vries, Elisabeth G. E. ;
Mahalingam, Devalingam ;
Meersma, Gert Jan ;
Ek, Wytske Boersma-van ;
Hollema, Harry ;
Hooge, Marjolijn N. Lub-de ;
van Dam, Go M. ;
Cool, Robbert H. ;
Quax, Wim J. ;
Samali, Afshin ;
van der Zee, Ate G. J. ;
de Jong, Steven .
CLINICAL CANCER RESEARCH, 2009, 15 (06) :2048-2057
[7]
Role of Activating Transcription Factor 3 (ATF3) in Endoplasmic Reticulum (ER) Stress-induced Sensitization of p53-deficient Human Colon Cancer Cells to Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL)-mediated Apoptosis through Up-regulation of Death Receptor 5 (DR5) by Zerumbone and Celecoxib [J].
Edagawa, Makoto ;
Kawauchi, Junya ;
Hirata, Manabu ;
Goshima, Hiroto ;
Inoue, Makoto ;
Okamoto, Tatsuro ;
Murakami, Akira ;
Maehara, Yoshihiko ;
Kitajima, Shigetaka .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (31) :21544-21561
[8]
A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage [J].
El-Khamisy, SF ;
Masutani, M ;
Suzuki, H ;
Caldecott, KW .
NUCLEIC ACIDS RESEARCH, 2003, 31 (19) :5526-5533
[9]
p53 Gene mutation, microsatellite instability and adjuvant chemotherapy:: Impact on survival of 388 patients with Dukes' C colon carcinoma [J].
Elsaleh, H ;
Powell, B ;
Soontrapornchai, P ;
Joseph, D ;
Goria, F ;
Spry, N ;
Iacopetta, B .
ONCOLOGY, 2000, 58 (01) :52-59
[10]
5-fluorouracil enhances exosome-dependent accumulation of polyadenylated rRNAs [J].
Fang, F ;
Hoskins, J ;
Butler, JS .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (24) :10766-10776